Effect of carbamazepine on the pharmacokinetic parameters of CDRI-97/78 following coadministration to rats

Drug Research

Volumn 63, Issue 6, 2013, Pages 282-288

  Kushwaha, H N ^a   Misra, A ^a   Gautam, N ^a   Singh, Y ^a   Kumar, H ^a   Siddiqui, H H ^b   Singh, S K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

97 63; animal; carbamazepine; drug drug interaction; LC MS MS; pharmacokinetics

Indexed keywords

ANTIMALARIAL AGENT; CARBAMAZEPINE; CDRI 97 78; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MONOTHERAPY; NONHUMAN; RAT; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84879474292     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1334921     Document Type: Article

References (42)

1. Singh C., Puri S. K. US Patent 6316493 B1: 2001
2. Singh C., Gupta N., Puri S. K. Photo-oxygenation of geraniol: Synthesis of a novel series of hydroxyl-functionalised antimalarial 1,2,4-trioxanes. Bioorg Med Chem Lett: 2002; 12 1913 1916 (Pubitemid 34756447)
3. Singh C., Malik H., Puri S. K. Orally active amino functionalized antimalarial 1,2,4-trioxanes. Bioorg Med Chem Lett: 2004; 14 459 462 (Pubitemid 38045145)
4. Singh C., Malik H., Puri S. K. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5] undecanes against multi-drug-resistant Plasmodium yoelii nigeriensis in mice. J Med Chem: 2006; 49 2794 2803
5. Singh C., Chaudhary S., Puri S. K. New orally active derivatives of artemisinine with high efficacy against multi-drug resistant malaria in mice. J Med Chem: 2006; 49 7227 7233 (Pubitemid 44886008)
6. Singh C., Sharma U., Saxena G. et al. Orally active antimalarials: Synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice. Bioorg Med Chem Lett: 2007; 17 4097 4101 (Pubitemid 47023152)
7. Singh C., Rani K., Sharma U. et al. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria. J Med Chem: 2007; 50 521 527 (Pubitemid 46239786)
8. Singh C., Verma V. P., Naikade N. et al. Novel bis-and tris-1, 2 4-trioxanes: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice. J Med Chem: 2008; 51 7581 7592
9. Griesbeck A. G., El-Idreesy T. T., Hoinck L. O. et al. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities. Bioorg Med Chem Lett: 2005; 15 595 597 (Pubitemid 40143130)
10. Singh R. P., Sabrinath S., Gautam N. et al. Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS/MS method for quantification. Arzeneimittelforschung: 2011; 61 120 125
11. Lang D. G., Wang C. M., Cooper B. R. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther: 1993; 266 829 835 (Pubitemid 23318697)
12. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol: 2006; 61 246 255 (Pubitemid 43382623)
13. Patsalo P. N., Frosher W., Pisani f. et al. The importance of drug interaction in epilepsy therapy. Epilepsia: 2002; 43 365 385 (Pubitemid 34297175)
14. Giessmann T., May K., Modess C. et al. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin Pharmacol Ther: 2004; 76 192 200 (Pubitemid 39221793)
15. Hermida J., Fernandez M. P., Tutor J. C. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. Clin Lab: 2002; 48 415 419 (Pubitemid 34823575)
16. Kerr B. M., Thummel K. E., Wurden C. J. et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol: 1994; 47 1969 1979
17. Parker A. C., Pritchard P., Preston T. et al. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol: 1998; 45 176 178
18. Schuetz E. G., Beck W. T., Schuetz J. D. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol: 1996; 49 311 318 (Pubitemid 26066117)
19. Fromm M. F., Kauffmann H. M., Fritz P. et al. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol: 2000; 157 1575 1580
20. Rae J. M., Johnson M. D., Lippman M. E. et al. Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther: 2001; 299 849 857 (Pubitemid 33104951)
21. Kim R. B. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev: 2002; 34 47 54 (Pubitemid 34311087)
22. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem: 2001; 276 14581 14587
23. Lehmann J. M., McKee D. D., Watson M. A. et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest: 1998; 102 1016 1023 (Pubitemid 28419246)
24. Synold T. W., Dussault I., Forman B. M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med: 2001; 7 584 590 (Pubitemid 32448326)
25. Kast H. R., Goodwin B., Tarr P. T. et al. Regulation of multidrug resistance associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem: 2002; 25 2908 2915 (Pubitemid 34953324)
26. Cherrington N. J., Hartley D. P., Li N. et al. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther: 2002; 300 97 104 (Pubitemid 34028514)
27. Sun J. J., Xie L., Liu X. D. Transport of carbamazepine and drug interactions at blood-brain barrier. Acta Pharmacol Sin: 2006; 27 249 253 (Pubitemid 43171166)
28. Usui T., Saitoh Y., Komada F. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull: 2003; 26 510 517 (Pubitemid 39663598)
29. Spina E., Pisani F., Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet: 1996; 31 198 214 (Pubitemid 26335906)
30. Terzano M. G., Salati M. R., Gemignani F. Asterix is associated with carbamazepine. Acta Neurol Belgium: 1983; 83 158 165
31. Shahzadi A., Javed I., Aslam bB Muhammad F. et al. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. Pak J Pharm Sci: 2011; 24 63 68
32. Medhi B., Singh P. K., Prakash A. et al. Effect of esomeprazole on the pharmacokinetics of carbamazepine. Indian J Pharmacol: 2011; 43 73 75
33. Brittencourt P. R., Gracia C. M., Martins R. et al. Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology: 1992; 42 492 496
34. Salvi B. S., Tremblay D., Surius A. et al. A study of the interaction of roxithromycin with theophylline and carbamazepine. J Antimicrob Chemother: 1987; 20 121 129 (Pubitemid 18003057)
35. Cawello W., Nickel B., Formella A. E. No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers. J Clin Pharmacol: 2010; 50 459 471
36. Penttila O., Neuvonen P. J., Aho K. et al. Interaction between doxycyclin and some antiepileptic drugs. Br Med J: 1974; 2 470 472
37. Damanhouri Z., Gumbleton M., Nicholls P. J. et al. In vivo effects of itraconazole on hepatic mixed function oxidase. J Antimicrob Chemother: 1988; 21 187 194
38. Ikeda T., Mori I., Komai T. et al. Interaction of cimetidine and ranitidine, the H2-receptor blockers, with mexazolam, a benzodiazepinooxazole- anxiolytic in rats. Xenobiot Metab Dispos: 1988; 3 395 405
39. Freireich E. J., Gehan E. A., Rall D. P. et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep: 1966; 50 219 244
40. Singh R. P., Sabarinath S., Gautam N. et al. Liquid chromatographic tandem mass spectrometric assay for quantitation of 97/78 and its metabolite 97/63: A promising trioxane antimalarial in monkey plasma. J Chromatogr B: 2009; 877 2074 2080
41. Ishigami M., Kawabata K., Takasaki W. et al. Drug interaction between simvastatin and itraconazole in male and female rats. Drug Metab Dispos: 2001; 29 1068 1072 (Pubitemid 32605924)
42. Kushwaha H. N., Gautam N., Misra A. et al. Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97/78, a novel trioxane antimalarial compound, in rats. Arzneimittelforschung: 2012; 62 274 279